Literature DB >> 7514359

Repeated endothelial removal augments intimal thickening and attenuates EDRF release.

Y Niimi1, H Azuma, K Hirakawa.   

Abstract

To evaluate the significance of repeated denudation injury in progression of atherosclerosis, we performed a single and then a second balloon denudation on the rabbit carotid arteries. Morphological examinations and organ chamber experiments were performed, and the results were compared. On morphological examinations, reendothelialization was almost completed in 2 wk after redenudation, whereas it required 6 wk after a single denudation. Intimal thickening progressed after redenudation. Organ chamber experiments showed that contractile responses and endothelium-independent relaxation remained unchanged after redenudation. Endothelium-dependent relaxations to acetylcholine, ADP, and substance P decreased progressively by repeating denudation. These relaxation responses were inhibited by NG-nitro-L-arginine, hemoglobin, and methylene blue and were considered to be associated with the production and/or release of endothelium-derived relaxing factor-nitric oxide (EDRF-NO). The diffusion barrier mechanism for the decreased endothelium-dependent relaxations was ruled out using sandwich experiments. In conclusion, repeated endothelial denudation caused progression of intimal thickening and acceleration of endothelial regeneration, and repeated endothelial regeneration resulted in progressively less production and/or release of EDRF-NO.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514359     DOI: 10.1152/ajpheart.1994.266.4.H1348

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Attenuated inhibition of adrenergic contraction by nitric oxide in injured guinea pig femoral artery.

Authors:  H Matsuda; A Kawaguchi; J Tamai; M Uematsu; S Nagata; K Miyatake
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

2.  Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice.

Authors:  Victoria Ulrich; Eddy S Konaniah; Wan-Ru Lee; Sadiksha Khadka; Yu-Min Shen; Joachim Herz; Jane E Salmon; David Y Hui; Philip W Shaul; Chieko Mineo
Journal:  J Am Heart Assoc       Date:  2014-10-14       Impact factor: 5.501

3.  Intimal hyperplasia in human uterine arteries accompanied by impaired synergism between prostaglandin I2 and nitric oxide.

Authors:  S Obayashi; T Aso; J Sato; H Hamasaki; H Azuma
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double-injury model.

Authors:  Y Inoue; K Toga; T Sudo; K Tachibana; S Tochizawa; Y Kimura; Y Yoshida; H Hidaka
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 5.  Novel biological functions of high-density lipoprotein cholesterol.

Authors:  Chieko Mineo; Philip W Shaul
Journal:  Circ Res       Date:  2012-09-28       Impact factor: 17.367

6.  Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia.

Authors:  H Masuda; M Goto; S Tamaoki; H Azuma
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

7.  Association between cholesterol efflux capacity and coronary restenosis after successful stent implantation.

Authors:  Satoshi Imaizumi; Shin-Ichiro Miura; Kohei Takata; Yosuke Takamiya; Takashi Kuwano; Makoto Sugihara; Amane Ike; Atsushi Iwata; Hiroaki Nishikawa; Keijiro Saku
Journal:  Heart Vessels       Date:  2015-09-04       Impact factor: 2.037

8.  Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L-arginine in regenerated endothelial cells.

Authors:  H Azuma; J Sato; H Hamasaki; A Sugimoto; E Isotani; S Obayashi
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

9.  Role of endothelium in the human uterine arteries during normal menstrual cycle.

Authors:  H Azuma; S Obayashi; H Hamasaki; T Koyama; T Aso
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

10.  Identification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis.

Authors:  Chieko Mineo; Lane Lanier; Eunjeong Jung; Samarpita Sengupta; Victoria Ulrich; Anastasia Sacharidou; Cristina Tarango; Olutoye Osunbunmi; Yu-Min Shen; Jane E Salmon; Rolf A Brekken; Xianming Huang; Philip E Thorpe; Philip W Shaul
Journal:  PLoS One       Date:  2016-07-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.